Tokyo, Japan

Kunio Shioda

This inventor holds 1 USPTO granted patent. Top assignees: Ajinomoto Co., Ltd., Other. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents
silverMedal1 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunio Shioda: Innovator in Cell Cleavage Technology

Introduction

Kunio Shioda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of cell division and reproduction efficiency. His innovative work has implications for both fertilized and unfertilized ova.

Latest Patents

Kunio Shioda holds a patent for a composition containing BUF-3 and superoxide dismutase as a cell cleavage promoting agent. This patent, which includes 1 patent, describes a cleavage promoting agent that comprises at least one of the polypeptides BUF-3, BUF-4, and BUF-5. This invention is particularly useful for enhancing cell division and improving reproduction efficiency.

Career Highlights

Throughout his career, Kunio Shioda has worked with prominent companies, including Ajinomoto Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas in biotechnology.

Collaborations

Kunio Shioda has collaborated with notable individuals in his field, including Hiroshiro Shibai and Michio Takahashi. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Kunio Shioda's contributions to biotechnology, particularly in cell cleavage technology, highlight his role as an influential inventor. His patent and collaborations reflect his commitment to improving reproductive efficiency through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…